Controlled release and antiviral activity of acyclovir-loaded PLA/PEG nanofibers produced by solution blow spinning. 2022

Kaline N Ferreira, and Raonil R Oliveira, and Lúcio R C Castellano, and Paulo R F Bonan, and Otavio V Carvalho, and Lindomar Pena, and Joelma R Souza, and Juliano E Oliveira, and Eliton S Medeiros
Post-Graduation Program in Materials Engineering (PPCEM), Laboratory of Materials and Biosystems (LAMAB), Federal University of Paraíba (UFPB), João Pessoa, PB, 58051-900, Brazil.

Herpetic dermatitis and oral recurrent herpes (ORH) are among the most common human infections. Antiviral drugs such as acyclovir (ACV) are used in the standard treatment for ORH. Despite its therapeutic efficacy, ACV is continuously and repetitively administered in high doses. In this sense, the development of controlled release drug delivery systems such as core-shell fibers have a great potential in the treatment of ORH. In this work, poly(lactic acid)/poly(ethylene glycol) (PLA/PEG) fibers were produced by solution blow spinning (SBS) for the controlled release of ACV encapsulated in the core. PLA/PEG nanofibers containing four different blend ratios (100:0, 90:10, 80:20 and 70:30 wt%) without or with 10 wt% ACV were characterized by scanning electron microscopy (SEM), thermogravimetry (TG) and differential scanning calorimetry (DSC). The ACV release profile for 21 days was accessed by UV-Vis spectroscopy. Static water contact angles of the spun fiber mats were measured by the sessile drop method to evaluate fiber wettability upon contact with skin for transdermal release. Cytotoxicity and antiviral efficacy against Herpes simplex viruses (HSV-1) were evaluated using Vero cells. ACV addition did not impact on morphology, but slightly improved thermal stability of the fibers. Addition of hydrophilic PEG in PLA/PEG blends, however, increased drug release as confirmed by contact angle measurements and release profile. The in vitro tests showed the effectiveness of the drug delivery systems developed in reducing HSV-1 viral titer, which is related to the judicious combination of polymers used in the fibrous mats, in addition to not being cytotoxic to Vero cells. These results show the great potential of PLA/PEG solution blow-spun fibers in the controlled release of ACV to develop practical devices for the treatment of cold sores, while favoring the aesthetic appearance by covering them with a soft tissue patch (fibrous mats).

UI MeSH Term Description Entries
D011091 Polyesters Polymers of organic acids and alcohols, with ester linkages--usually polyethylene terephthalate; can be cured into hard plastic, films or tapes, or fibers which can be woven into fabrics, meshes or velours. Polyester
D011092 Polyethylene Glycols Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS. Macrogols,Polyoxyethylenes,Carbowax,Macrogol,Polyethylene Glycol,Polyethylene Oxide,Polyethyleneoxide,Polyglycol,Glycol, Polyethylene,Glycols, Polyethylene,Oxide, Polyethylene,Oxides, Polyethylene,Polyethylene Oxides,Polyethyleneoxides,Polyglycols,Polyoxyethylene
D002522 Chlorocebus aethiops A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research. African Green Monkey,Cercopithecus aethiops,Cercopithecus griseoviridis,Cercopithecus griseus,Cercopithecus pygerythrus,Cercopithecus sabeus,Cercopithecus tantalus,Chlorocebus cynosuros,Chlorocebus cynosurus,Chlorocebus pygerythrus,Green Monkey,Grivet Monkey,Lasiopyga weidholzi,Malbrouck,Malbrouck Monkey,Monkey, African Green,Monkey, Green,Monkey, Grivet,Monkey, Vervet,Savanah Monkey,Vervet Monkey,Savannah Monkey,African Green Monkey,Chlorocebus cynosuro,Green Monkey, African,Green Monkeys,Grivet Monkeys,Malbrouck Monkeys,Malbroucks,Monkey, Malbrouck,Monkey, Savanah,Monkey, Savannah,Savannah Monkeys,Vervet Monkeys
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000212 Acyclovir A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. Acycloguanosine,9-((2-Hydroxyethoxy)methyl)guanine,Aci-Sanorania,Acic,Aciclobeta,Aciclostad,Aciclovir,Aciclovir Alonga,Aciclovir-Sanorania,Acifur,Acipen Solutab,Acivir,Activir,Acyclo-V,Acyclovir Sodium,Antiherpes Creme,Avirax,Cicloferon,Clonorax,Cusiviral,Genvir,Herpetad,Herpofug,Herpotern,Herpoviric,Isavir,Laciken,Mapox,Maynar,Milavir,Opthavir,Supraviran,Viclovir,Vipral,Virax-Puren,Virherpes,Virmen,Virolex,Virupos,Virzin,Wellcome-248U,Zoliparin,Zovirax,Zyclir,aciclovir von ct,Aci Sanorania,Aciclovir Sanorania,Acyclo V,Alonga, Aciclovir,Sodium, Acyclovir,Solutab, Acipen,Virax Puren,ViraxPuren,Wellcome 248U,Wellcome248U
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D014709 Vero Cells A CELL LINE derived from the kidney of the African green (vervet) monkey, (CHLOROCEBUS AETHIOPS) used primarily in virus replication studies and plaque assays. Cell, Vero,Cells, Vero,Vero Cell
D057139 Nanofibers Submicron-sized fibers with diameters typically between 50 and 500 nanometers. The very small dimension of these fibers can generate a high surface area to volume ratio, which makes them potential candidates for various biomedical and other applications. Nanofiber

Related Publications

Kaline N Ferreira, and Raonil R Oliveira, and Lúcio R C Castellano, and Paulo R F Bonan, and Otavio V Carvalho, and Lindomar Pena, and Joelma R Souza, and Juliano E Oliveira, and Eliton S Medeiros
May 2021, Membranes,
Kaline N Ferreira, and Raonil R Oliveira, and Lúcio R C Castellano, and Paulo R F Bonan, and Otavio V Carvalho, and Lindomar Pena, and Joelma R Souza, and Juliano E Oliveira, and Eliton S Medeiros
April 2019, IEEE transactions on nanobioscience,
Kaline N Ferreira, and Raonil R Oliveira, and Lúcio R C Castellano, and Paulo R F Bonan, and Otavio V Carvalho, and Lindomar Pena, and Joelma R Souza, and Juliano E Oliveira, and Eliton S Medeiros
June 2017, Journal of food science,
Kaline N Ferreira, and Raonil R Oliveira, and Lúcio R C Castellano, and Paulo R F Bonan, and Otavio V Carvalho, and Lindomar Pena, and Joelma R Souza, and Juliano E Oliveira, and Eliton S Medeiros
March 2014, ACS macro letters,
Kaline N Ferreira, and Raonil R Oliveira, and Lúcio R C Castellano, and Paulo R F Bonan, and Otavio V Carvalho, and Lindomar Pena, and Joelma R Souza, and Juliano E Oliveira, and Eliton S Medeiros
March 2022, Science advances,
Kaline N Ferreira, and Raonil R Oliveira, and Lúcio R C Castellano, and Paulo R F Bonan, and Otavio V Carvalho, and Lindomar Pena, and Joelma R Souza, and Juliano E Oliveira, and Eliton S Medeiros
September 2022, Nanotechnology,
Kaline N Ferreira, and Raonil R Oliveira, and Lúcio R C Castellano, and Paulo R F Bonan, and Otavio V Carvalho, and Lindomar Pena, and Joelma R Souza, and Juliano E Oliveira, and Eliton S Medeiros
February 2018, International journal of molecular sciences,
Kaline N Ferreira, and Raonil R Oliveira, and Lúcio R C Castellano, and Paulo R F Bonan, and Otavio V Carvalho, and Lindomar Pena, and Joelma R Souza, and Juliano E Oliveira, and Eliton S Medeiros
June 2017, Analytical methods : advancing methods and applications,
Kaline N Ferreira, and Raonil R Oliveira, and Lúcio R C Castellano, and Paulo R F Bonan, and Otavio V Carvalho, and Lindomar Pena, and Joelma R Souza, and Juliano E Oliveira, and Eliton S Medeiros
August 2022, International journal of biological macromolecules,
Kaline N Ferreira, and Raonil R Oliveira, and Lúcio R C Castellano, and Paulo R F Bonan, and Otavio V Carvalho, and Lindomar Pena, and Joelma R Souza, and Juliano E Oliveira, and Eliton S Medeiros
October 2023, Nanotechnology,
Copied contents to your clipboard!